Wow, go pf_老虎社区_美港股上老虎

Bankai
2021-12-31

Wow, go pfzier!

Pfizer’s Antiviral Covid-19 Pill Approved by U.K. Regulator

Britain’s regulator approved Pfizer Inc.’s Covid-19 antiviral pill, just weeks after clearing rival

Pfizer’s Antiviral Covid-19 Pill Approved by U.K. Regulator

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":692643457,"tweetId":"692643457","gmtCreate":1640956309205,"gmtModify":1640956309397,"author":{"id":3558673211102792,"authorId":3558673211102792,"authorIdStr":"3558673211102792","name":"Bankai","avatar":"https://static.tigerbbs.com/c7e0e10df42a0abec55080b7e549ec86","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Wow, go pfzier!&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Wow, go pfzier!&nbsp;</p></body></html>","text":"Wow, go pfzier!","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/692643457","repostId":1133193949,"repostType":4,"repost":{"id":"1133193949","pubTimestamp":1640952268,"share":"https://www.laohu8.com/m/news/1133193949?lang=&edition=full","pubTime":"2021-12-31 20:04","market":"us","language":"en","title":"Pfizer’s Antiviral Covid-19 Pill Approved by U.K. Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1133193949","media":"Bloomberg","summary":"Britain’s regulator approved Pfizer Inc.’s Covid-19 antiviral pill, just weeks after clearing rival ","content":"<html><head></head><body><p>Britain’s regulator approved Pfizer Inc.’s Covid-19 antiviral pill, just weeks after clearing rival Merck &amp; Co.’s oral treatment.</p><p>The Pfizer drug, Paxlovid, was authorized for use in people over 18 with mild to moderate Covid and at least one risk factor for developing severe illness, the U.K.’s Medicines and Healthcare Products Regulatory Agency said Friday.</p><p>Prime Minister Boris Johnson’s government wants an armory of weapons to fight the pandemic, including vaccines and antiviral treatments, and has been rolling them out as fast as it can as the omicron variant advances.</p><p>Britain has ordered 2.75 million courses of the Pfizer drug, which gained emergency use authorization in the U.S. last week. The U.K. has also ordered Merck’s pill, molnupiravir, developed with partner Ridgeback Biotherapeutics LP, which was approved by the British regulator in November.</p></body></html>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer’s Antiviral Covid-19 Pill Approved by U.K. Regulator</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer’s Antiviral Covid-19 Pill Approved by U.K. Regulator\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-31 20:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-31/pfizer-s-antiviral-covid-19-pill-approved-by-u-k-regulator><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Britain’s regulator approved Pfizer Inc.’s Covid-19 antiviral pill, just weeks after clearing rival Merck & Co.’s oral treatment.The Pfizer drug, Paxlovid, was authorized for use in people over 18 ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-31/pfizer-s-antiviral-covid-19-pill-approved-by-u-k-regulator\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-31/pfizer-s-antiviral-covid-19-pill-approved-by-u-k-regulator","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133193949","content_text":"Britain’s regulator approved Pfizer Inc.’s Covid-19 antiviral pill, just weeks after clearing rival Merck & Co.’s oral treatment.The Pfizer drug, Paxlovid, was authorized for use in people over 18 with mild to moderate Covid and at least one risk factor for developing severe illness, the U.K.’s Medicines and Healthcare Products Regulatory Agency said Friday.Prime Minister Boris Johnson’s government wants an armory of weapons to fight the pandemic, including vaccines and antiviral treatments, and has been rolling them out as fast as it can as the omicron variant advances.Britain has ordered 2.75 million courses of the Pfizer drug, which gained emergency use authorization in the U.S. last week. The U.K. has also ordered Merck’s pill, molnupiravir, developed with partner Ridgeback Biotherapeutics LP, which was approved by the British regulator in November.","news_type":1},"isVote":1,"tweetType":1,"viewCount":524,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":13,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Pfizer’s Antiviral Covid-19 Pill Approved by U.K. Regulator

评论（1）

热议股票